We recently published a list of Jim Cramer’s List of 16 Stocks to Buy Right Now. In this article, we are going to take a look ...

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

To get a sense of who is truly in control of Cardinal Health, Inc. (NYSE:CAH), it is important to understand the ownership ...

We recently published a list of Jim Cramer is Bullish on These 10 Stocks. In this article, we are going to take a look at ...

Citi analyst Daniel Grosslight maintained a Hold rating on Cardinal Health (CAH – Research Report) today and set a price target of $140.00. The ...

Yes, I do think we need non-glucocorticoid forms of therapy to treat 21-hydroxylase deficiency congenital adrenal hyperplasia.The most common form of congenital adrenal hyperplasia (CAH) is a ...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could ...

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Cardinal Health (CAH – Research Report), with a price ...

The South San Francisco biotech has acquired rights to tralesinidase alfa, an enzyme replacement therapy (ERT) for the ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...